Glenn J. Lesser, MD
- Professor, Cancer Medicine (Winston-Salem)

Glenn J. Lesser, MD
- Professor, Cancer Medicine (Winston-Salem)
Research Interests
- Glioma
- Glioblastoma
- Low-Grade Glioma
- Clinical Trials
- Neuro-Oncology
- Brain Tumors
- Education
- MD, Pennsylvania State University College of Medicine, 1987
- Internship
- Internal Medicine, Wake Forest University School of Medicine, 1988
- Residency
- Internal Medicine, Wake Forest University School of Medicine, 1991
- Fellowship
- Oncology, Johns Hopkins Hospital, 1994
- Board Certifications
- American Board of Internal Medicine, Medical Oncology
- Memberships
- American Society of Clinical Oncology
- American Medical Association
- Southern Medical Association
- American College of Physicians Fellow
- Society of Neuro-Oncology
- Southern Association For Oncology
- North Carolina Medical Association
- Positions
- Professor, Cancer Medicine (Winston-Salem)
- Professor, Neurological Surgery (Winston-Salem)
- Professor, Public Health Sciences (Winston-Salem)
- Professor, Anesthesiology (Winston-Salem)
- Departments and Affiliations
- Cancer Medicine (Winston-Salem)
- Neurological Surgery (Winston-Salem)
- Public Health Sciences (Winston-Salem)
- Anesthesiology (Winston-Salem)
- Cardiovascular Sciences Center (CVSC)
- Comprehensive Cancer Center (CCC)
- Hypertension and Vascular Research Center
Research
- The management of thromboembolic disease in patients with central nervous system malignancies. Knovich MA, Lesser GJ. Curr Treat Options Oncol. 2004 Dec; 5(6):511-7.
- Current controversies in the radiotherapeutic management of adult low-grade glioma. Shaw EG, Tatter SB, Lesser GJ, Ellis TL, Stanton CA, Stieber VW. Semin. Oncol. 2004 Oct; 31(5):653-8.
- Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT. Clin. Cancer Res. 2004 Sep; 10(17):5643-6.
- Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11. Batchelor TT, Gilbert MR, Supko JG, Carson KA, Nabors LB, Grossman SA, Lesser GJ, Mikkelsen T, Phuphanich S. Neuro-oncology. 2004 Jan; 6(1):21-7.
- Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study. Laterra JJ, Grossman SA, Carson KA, Lesser GJ, Hochberg FH, Gilbert MR. Neuro-oncology. 2004 Jan; 6(1):15-20.